In the notice, the DEA said Kratom is an "increasingly popular drug of abuse." The DEA also said the opioids mitragynine and 7-hydroxymitragynine have a high potential for abuse, no currently accepted medical use in treatment in the U.S. and a lack of accepted safety for use under medical supervision.